Insulin resistance is the most under-discussed cardiovascular risk factor in ordinary health conversation, and the reason is that it has no symptom and no routine test. It sits upstream of the things that do get measured, and by the time it shows up as diabetes it has usually been present for years.
The evidence that it matters for the heart is strong. Unusually for this kind of topic, the causal case is not purely observational.
What it is, and why it is hard to measure
Insulin resistance is a determining factor in the pathophysiology of type 2 diabetes.[1] The body’s tissues respond less to insulin, the pancreas compensates by producing more, and for a long stretch of that process blood glucose looks normal.
Measurement is the practical problem. The hyperinsulinaemic-euglycaemic clamp is the reference method, and research comparing surrogate indices is explicitly framed around which one correlates best with it.[2] The clamp takes hours and requires a research setting, so nobody is getting one at a checkup.
What gets used instead are proxies. The homeostatic model assessment is the reference comparator when simpler surrogate indices are evaluated.[3] All of these are approximations, and that limits how precisely any of the risk estimates below can be read.
Why this matters for interpretation: every association in this article is between a proxy for insulin resistance and an outcome. The proxies are good, not perfect.
The association with cardiovascular outcomes
A meta-analysis examined insulin resistance markers including HOMA-IR against the risk of incident cardiovascular events.[4] Insulin resistance measured by estimated glucose disposal rate is likewise associated with cardiovascular disease in cohort data.[5]
The finding holds using simpler markers too. A meta-analysis of the triglyceride-glucose index, an indicator of insulin resistance, found it associated with coronary artery disease.[6] That the association survives across several different proxies is reassuring: it suggests the underlying biology is being detected rather than an artefact of one measurement method.
The route from insulin resistance to arteries
The lipid picture is the clearest mechanistic link. High triglycerides with low HDL cholesterol are characteristic of the metabolic syndrome, and the triglyceride to HDL ratio has been studied as a marker in its own right.[7]
This is worth knowing practically, because that lipid pattern is visible on a standard blood panel. A normal LDL alongside high triglycerides and low HDL is a metabolic signal that routine cholesterol screening tends to underweight.
Insulin resistance also does not travel alone. It is one component of the metabolic syndrome, a cluster of factors that together increase cardiovascular disease risk.[8] That clustering is what makes its independent contribution genuinely difficult to isolate in observational data.
Is it causal?
Here the evidence goes further than most nutrition and metabolism topics manage.
A Mendelian randomization analysis examined the causal association of insulin resistance with coronary artery disease.[9] The method uses genetic variants that affect insulin sensitivity as a natural experiment: genes are allocated at conception, before lifestyle or illness can confound anything, so an association across genotype is much harder to explain away as reverse causation.
This is why insulin resistance deserves more attention than the average risk marker. Most cardiovascular associations in popular health writing rest on cohort correlations alone. This one has genetic evidence behind it.
What moves it
All three of the interventions with real evidence are unglamorous.
Exercise. A randomized comparison of high-intensity interval training against moderate-intensity continuous training measured effects on insulin sensitivity directly.[10] Both modalities were worth comparing, which tells you the effect is not confined to one style of training.
Weight loss, in gradations. A controlled study examined the precise metabolic effects of 5% weight loss and further loss beyond it in people with obesity.[11] The 5% figure is not arbitrary; it was tested.
Both together, at scale. A randomized trial showed prevention of type 2 diabetes by changes in lifestyle in people with impaired glucose tolerance.[12] This is the hard endpoint: not a marker moving, but fewer people developing the disease.
What this article could not establish
Two claims were removed for want of supporting sources: that insulin resistance is associated with endothelial dysfunction, and that it is associated with systemic inflammation contributing to plaque development. Both are standard textbook mechanisms and very likely true. The searches returned adjacent papers rather than sources that state them, so they are not asserted here.
What follows
If you want one number that says something about metabolic health beyond what a standard cholesterol panel tells you, fasting triglycerides alongside HDL is a reasonable start, and fasting insulin adds more.
The interventions are the ones you already know. What the genetic evidence adds is confidence that you are treating a cause rather than watching a symptom.
This article is for research and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The peptides discussed here are sold for research use only and are not for human consumption. Nothing in this article constitutes medical advice. Consult a qualified clinician before making changes to a health, training, or supplementation protocol.
References
Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis.. Annals of physical and rehabilitation medicine, 2019.
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis.. Diabetologia, 2014.
Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis.. PloS one, 2012.
Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study.. Cardiovascular diabetology, 2024.
Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis.. Cardiovascular diabetology, 2023.
Triglyceride/High-Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis.. Lipids, 2021.
A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.. Schizophrenia research, 2016.
Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis.. BMJ open diabetes research & care, 2020.
Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults.. The Journal of clinical endocrinology and metabolism, 2020.
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity.. Cell metabolism, 2016.
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.. The New England journal of medicine, 2001.
